EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Serum Uric Acid as a Sex‐Dependent Risk Marker of Post‐Stroke Epilepsy After Acute Ischemic Stroke: Complementary Mendelian Randomization and Cohort Analyses

Serumharnsäure als geschlechtsabhängiger Risikomarker für poststroke Epilepsie nach akutem ischämischem Schlaganfall: ergänzende Mendelian-Randomization- und Kohortenanalysen

Yan Cheng, Ji Li, Yunzhou Yang iD

CNS Neuroscience & Therapeutics · 2026-06 · 32 (6)

DOI: 10.1002/cns.70970 ↗

Auf einen Blick

Eine Mendelian-Randomization-Analyse fand keinen Hinweis auf eine gemeinsame genetische Kausalarchitektur zwischen Serumharnsäure und allgemeiner Epilepsieanfälligkeit. In der Kohorte zeigte sich dagegen eine geschlechtsabhängige, nichtlineare Assoziation mit poststroke Epilepsie.

Fragestellung

Besteht bei akutem ischämischem Schlaganfall ein kausaler Zusammenhang zwischen Serumharnsäure und poststroke Epilepsie, und verbessert Serumharnsäure die Vorhersage?

Methode

Zwei-Sample-Mendelian-Randomization mit 299 genetischen Instrumenten; parallel multizentrische AIS-Kohorte (n = 21.459) mit logistischer Regression, restricted cubic splines, Sex-Interaktion und Vorhersageanalysen.

Ergebnisse

MR: kein Zusammenhang (IVW: OR 1,043; 95 %-KI 0,926–1,174; p = 0,487). Kohorte: 936 PSE-Ereignisse (4,36 %), nichtlineare SUA–PSE-Assoziation. Frauen im höchsten SUA-Tertil: OR 2,33 (95 %-KI 1,71–3,19); Männer: OR 0,36 (95 %-KI 0,28–0,46).

Einschränkungen

Beobachtungsanalyse und MR adressieren unterschiedliche biologische Fragen; externe Validierung fehlt.

Schlussfolgerung der Autor:innen

Genetisch vorhergesagte Lebenszeit-Serumharnsäure teilt keine kausale genetische Architektur mit allgemeiner Epilepsieanfälligkeit. Die geschlechtsabhängige Beobachtungsassoziation sollte prospektiv geprüft werden.

Kernaussagen

  • MR ohne Hinweis auf kausale Beziehung zur allgemeinen Epilepsieanfälligkeit
  • In der Kohorte nichtlineare SUA–PSE-Assoziation mit Sex-Interaktion
  • SUA verbesserte die Diskrimination des klinischen Modells geringfügig

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Multizentrische Studie in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 08.06.2026. Verfasst von Yan Cheng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Lu'an People's Hospital (The Affiliated Lu'an Hospital of Anhui Medical University), Lu'an, Anhui, China. Hauptthemen laut MEDLINE: Uric Acid, Ischemic Stroke, Epilepsy, Mendelian Randomization Analysis. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Observational studies have consistently reported associations between serum uric acid (SUA) and post‐stroke epilepsy (PSE) in acute ischemic stroke (AIS), including a recently published large cohort study identifying a U‐shaped relationship. However, whether these associations reflect causality and whether SUA provides incremental predictive value beyond established clinical factors remains unknown. Methods we conducted a two‐sample Mendelian randomization ( MR ) analysis to test whether lifelong genetically predicted serum urate shares a genetic causal architecture with general epilepsy susceptibility, using 299 independent genetic instruments. In parallel, we performed a prespecified secondary analysis of a multicenter AIS cohort ( n = 21,459) using multivariable logistic regression with restricted cubic splines ( RCS ) to characterize the observational SUA – PSE relationship. Formal sex interaction testing (Wald tests) and sex‐stratified spline analyses were performed. Predictive utility was evaluated through discrimination ( AUC ), calibration, decision curve analysis ( DCA ), and internal validation with 1000 bootstrap resamples. The two analytical components address related but distinct biological questions: observational analysis tests the admission‐ SUA ‐to‐1‐year‐ PSE pathway, while MR tests whether lifelong genetically predicted urate shares a causal architecture with general epilepsy susceptibility.

Results

MR analysis found no evidence supporting a shared lifelong genetic causal architecture between serum urate and general epilepsy susceptibility across all four methods (IVW: OR = 1.043, 95% CI 0.926–1.174, p = 0.487; MR‐Egger p = 0.582; weighted median p = 0.589; weighted mode p = 0.996), with no pleiotropy (Egger intercept p = 0.865) or heterogeneity (Cochran Q p = 0.206). In the observational cohort ( n = 21,459; 936 PSE events (4.36%)), RCS analyses confirmed a significant nonlinear SUA–PSE association (P for nonlinearity < 0.001). Importantly, a formal sex‐by‐SUA interaction revealed strikingly divergent patterns (overall p < 0.001; nonlinear component p = 0.0002): Women in the highest SUA tertile had markedly elevated PSE risk (adjusted OR = 2.33, 95% CI 1.71–3.19), a finding confirmed with sex‐specific tertile cut‐points (OR = 1.50, p = 0.005). The apparent protective association in men using overall tertiles (OR = 0.36, 95% CI 0.28–0.46) was attenuated and non‐significant with sex‐specific cut‐points (OR = 0.84, p = 0.16), indicating sensitivity to stratification method. Adding SUA to a base clinical model produced a modest but statistically significant increment in discrimination (AUC: 0.8498 to 0.8607, ΔAUC = 0.011, DeLong p = 0.001) with consistent positive net benefit on DCA.

Conclusions

Genetically predicted lifelong SUA does not share a causal genetic architecture with general epilepsy susceptibility; this null does not exclude acute post‐stroke, context‐specific mechanisms, which operate on biological timescales outside the scope of Mendelian randomization. The sex‐dependent observational association (female high‐SUA OR = 1.50 with sex‐specific tertiles; sex × SUA continuous interaction p = 3.99 × 10 −9 ) generates the hypothesis that sex‐stratified SUA monitoring merits prospective investigation, pending external validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uric AcidIschemic StrokeEpilepsyMendelian Randomization AnalysisSex CharacteristicsHumansMaleFemaleCohort StudiesBiomarkersRisk FactorsMiddle AgedStroke

Stichwörter der Autor:innen

Mendelian randomizationacute ischemic strokecausal inferencepost‐stroke epilepsypredictive utilityrestricted cubic splineserum uric acidsex interaction

Substanzen

Uric AcidBiomarkers

Autor:innen und Institutionen

  • Department of Neurology, Lu'an People's Hospital (The Affiliated Lu'an Hospital of Anhui Medical University), Lu'an, Anhui, China.

ORCID-Profile: Yunzhou Yang

Zitieren

APA

Cheng, Y., Li, J., & Yang, Y. (2026). Serum Uric Acid as a Sex‐Dependent Risk Marker of Post‐Stroke Epilepsy After Acute Ischemic Stroke: Complementary Mendelian Randomization and Cohort Analyses. CNS Neuroscience & Therapeutics, 32(6). https://doi.org/10.1002/cns.70970

Vancouver

Cheng Y, Li J, Yang Y. Serum Uric Acid as a Sex‐Dependent Risk Marker of Post‐Stroke Epilepsy After Acute Ischemic Stroke: Complementary Mendelian Randomization and Cohort Analyses. CNS Neuroscience & Therapeutics. 2026;32(6). doi:10.1002/cns.70970

BibTeX
@article{Cheng2026,
  author = {Cheng, Yan and Li, Ji and Yang, Yunzhou},
  title = {Serum Uric Acid as a Sex‐Dependent Risk Marker of Post‐Stroke Epilepsy After Acute Ischemic Stroke: Complementary Mendelian Randomization and Cohort Analyses},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  volume = {32},
  number = {6},
  doi = {10.1002/cns.70970}
}
Kostenlos starten →